http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 09 Oct 2025 09:30:00 +0000 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/Press+Releases/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344 http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html <div class="xn-content"> <p class="prntaj"> <i>Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community</i> </p> <p> <span http://www.streetinsider.com/PRNewswire/Stealth+BioTherapeutics+Announces+Mito+Assist%E2%84%A2+Patient+Support+Program+and+Specialty+Pharmacy+Partnership+with+AnovoRx+to+Distribute+FORZINITY%E2%84%A2%28elamipretide%29+injection/25438774.html Thu, 09 Oct 2025 09:30:00 +0000 A.06822034 A.21849991 A.50114110 MITO O.00180425 O.20026344